Amanote Research
Register
Sign In
FDA Will Increase Postmarketing Surveillance of Drugs
BMJ
doi 10.1136/bmj.329.7476.1203-a
Full Text
Open PDF
Abstract
Available in
full text
Date
November 20, 2004
Authors
J. H. Tanne
Publisher
BMJ
Related search
Postmarketing Surveillance of Adverse Drug Reactions
BMJ
Postmarketing Surveillance Study of Permethrin Creme Rinse.
American Journal of Public Health
Environmental
Public Health
Occupational Health
FDA Approval of New Drugs
JAMA - Journal of the American Medical Association
Medicine
FDA Approval of Obesity Drugs
JAMA - Journal of the American Medical Association
Medicine
Postmarketing Surveillance of the Safety and Effectiveness of Etanercept in Japan
Journal of Rheumatology
Rheumatology
Allergy
Immunology
Development, Production, and Postmarketing Surveillance of Hepatitis a Vaccines in China
Journal of Epidemiology
Medicine
Epidemiology
FDA Warning to Manufacturers of AIDS Drugs
Western Journal of Medicine
The FDA Warning on Anesthesia Drugs
Anesthesia Progress
Anesthesiology
Pain Medicine
Repurposing FDA-approved Drugs for Anti-Aging Therapies
Biogerontology
Aging
Gerontology
Geriatrics